California medical device company RenovoRx’s Trans-Arterial Micro-Perfusion (TAMP) system has shown potential for improved ...

Global Intraosseous Devices Market Set for Significant Growth, Projected to Reach USD 938.6 Million by 2035 Driven by Growing Demand and Technological Advancements. The U.S. leads the intraosseous ...

Becton, Dickinson & Co. plans to close its Caesarea Medical Electronics, a producer of infusion pump systems, by June and ...

Learn more The best streaming devices enable quick access to popular TV apps, allowing you to watch your favorite movies and shows with ease. Though most modern displays have built-in smart TV ...

BlissRoms-Devices/android_device_realme-sm8250-common’s past year of commit activity ...

The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Find out how an extravasation risk rating system introduced for all IV medicines has led to increased patient safety across ...

The global disposable syringes market size was valued at USD 15.81 billion in 2024 and is projected to reach from USD 16.75 ...

The Universal Device Detection library will parse any User Agent and detect the browser, operating system, device used (desktop, tablet, mobile, tv, cars, console, etc.), brand and model.

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery platform, today ...